About this journal
Aims and scope
Clinical Toxicology aims to be the journal of primary interest to practicing clinical toxicologists, whether in hospitals, poison centres, academia, government or industry. The journal is relevant to all professionals at the interface of clinical toxicology with acute care, occupational and environmental medicine, public health, regulatory toxicology, pharmacology and pharmaceutics, and analytical and forensic pathology.
The journal welcomes for consideration the following article types: Clinical Research, Basic Research, Poison Centre Research, Methods, Reviews, Toxicological History, Images, Letters to the Editor: Original Scientific Contributions, Letters, and Commentaries. All articles received by the Journal will be subject to double-anonymous peer review.
Journal metrics
Usage
- 506K annual downloads/views
Citation metrics
- 3.0 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 3.1 (2023) 5 year IF
- 5.7 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 1.294 (2023) SNIP
- 0.956 (2023) SJR
Speed/acceptance
- 4 days avg. from submission to first decision
- 18 days avg. from submission to first post-review decision
- 26 days avg. from acceptance to online publication
- 27% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
CO-EDITORS-IN-CHIEF
Professor Robert S. Hoffman – NYU Grossman School of Medicine and Bellevue Hospital Center, New York, NY, USA
Professor Allister Vale – City Hospital and University of Birmingham, Birmingham, West Midlands, UK
DEPUTY EDITORS
Professor Nicholas Buckley – University of Sydney, RPA Hospital and NSW Poisons Information Centre, Sydney, NSW, Australia
Professor Donna Seger – Vanderbilt University Medical Center, Nashville, TN, USA
Professor Simon Thomas – Newcastle University, Newcastle-upon-Tyne, Tyne and Wear, UK
REVIEWS EDITOR
Professor Michael Mullins – Washington University School of Medicine, Saint Louis, MO, USA
ASSOCIATE EDITORS
Dr Betty Chan – School of Clinical Medicine at University of New South Wales and Prince of Wales Hospital, Sydney, NSW, Australia
Professor Thomas Y. K. Chan – Centre for Food and Drug Safety, The Chinese University of Hong Kong, Hong Kong, China
Professor Kirk Cumpston – Virginia Commonwealth University Health System and Virginia Poison Center, Richmond, VA, USA
Dr Ronald I. Kirschner – University of Nebraska, Omaha, NE, USA
Professor Bruno Mégarbane – Paris Cité University, Lariboisière Hospital (APHP) and INSERM UMRS-1144, Paris, Île-de-France, France
Decision Editor Conflict of Interest Statements are available here.
STATISTICS EDITOR
Dr Darsy Darssan – The University of Queensland, Brisbane, QL, Australia
SOCIAL MEDIA EDITOR
Professor David Juurlink – University of Toronto, Toronto, Canada
Dr Joshua Trebach – University of Iowa Hospitals and Clinics, Iowa City, IA; Iowa Poison Control Center, Sioux City, IA, USA
SENIOR EDITORIAL BOARD
Professor Paul I. Dargan – Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, Greater London, UK
Professor Dylan de Lange – Dutch Poisons Information Center, University Medical Center, Utrecht, Netherlands
Professor Michael Eddleston – University of Edinburgh, Edinburgh, UK; South Asian Clinical Toxicology Research Collaboration (SACTRC), Peradeniya, Sri Lanka
Professor Michael G. Holland – SUNY Upstate Medical University and Upstate New York Poison Center, Syracuse, NY; Saratoga Hospital Employee Health Director; Saratoga Springs, NY; Glens Falls Hospital Employee Health Director, Glens Falls, NY, USA
Professor Christopher Holstege – University of Virginia School of Medicine, Charlottesville, VA, USA
Professor Geoff Isbister – University of Newcastle, Newcastle, Australia
Dr Hugo Kupferschmidt – Former Director of Tox Info Suisse, Zürich, Switzerland; Former Head of the Poisons Centre at Charité-University Medicine Berlin, Berlin, Germany
Dr James B. Mowry – Indiana Poison Center and Indiana University School of Medicine, Indianapolis, IN, USA
Dr Darren Roberts – Edith Collins Centre at Royal Prince Alfred Hospital and New South Wales Poisons Information Centre, Children’s Hospital Westmead, Sydney, NSW, Australia
Dr Jay L. Schauben – Florida Poison Information Center and University of Florida College of Medicine, Jacksonville, FL, USA
Dr Karen Simone – Northern New England Poison Center at Maine Health, Portland, ME; Tufts University, Boston, MA, USA
Professor Horst Thiermann – Bundweswehr Institute of Pharmcology and Toxicology, Munich, Bavaria, Germany
EDITORIAL BOARD
Dr Mohamed Fahim – University of New South Wales, Sydney, NSW, Australia; University of Peradeniya, Peradeniya, Sri Lanka; National Poison Centre, Universiti Sains Malaysia, Penang, Malaysia (Fellow-in-Training)
Dr Niko Amend – Bundeswehr Institute of Pharmacology and Toxicology, and Walther-Straub-Institute of Pharmacology and Toxicology, Munich, Bavaria, Germany (Fellow-in-Training)
Dr Kevin Baumgartner – Washington University School of Medicine, St. Louis, MO, USA
Professor (Emeritus) Yedidia Bentur - Technion-Israel Institute of Technology, Haifa, Israel
Dr Sean M. Bryant – Cook County Health, Toxikon Consortium and Illinois Poison Center, Chicago, IL, USA
Dr Rose Cairns – The University of Sydney and New South Wales Poisons Information Centre, Sydney, NSW, Australia
Dr Angela L. Chiew – Prince of Wales Hospital, NSW Poisons Information Centre and UNSW Medicine, Sydney, NSW, Australia
Professor Florian Eyer – Technical University of Munich, Munich, Germany
Professor Robert G. Hendrickson – Oregon Poison Center and Oregon Health and Science University, Portland, OR, USA
Dr Ana Ferrer-Dufol – Clinic University Hospital and Medical School. Zaragoza University; Zaragoza, Spain
Dr Christopher O. Hoyte (Coordinator, Fellow in Training Program) – Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, and Department of Emergency Medicine at University of Colorado School of Medicine, Aurora, CO, USA
Dr Davide Lonati – Pavia Poison Control Centre and Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Lombardy, Italy
Dr HoanVu Nguyen – University of California, Sacramento, CA,, USA (Fellow-in-Training)
Dr Robert Palmer – Rocky Mountain Poison & Drug Service and University of Colorado, Denver, CO; Toxicology Associates, PLLC, Littleton, CO, USA
Professor Elizabeth J. Scharman – West Virginia University School of Pharmacy and WV Poison Center, Charleston, WV, USA
Professor Anjana Silva – Rajarata University of Sri Lanka, Anuradhapura, North Central Province, Sri Lanka
Dr Brandon J. Warrick – University of New Mexico, Albuquerque, NM, USA
Professor Saralyn R. Williams – Vanderbilt University School of Medicine, Nashville, TN, USA
Dr Bryan Wilson – Arizona Poison & Drug Information Center, Tucson, AZ, USA
Professor Chen-Chang Yang – National Yang Ming Chiao Tung University and Taipei Veterans General Hospital, Taipei, Northern Taiwan, Taiwan
Professor Sergey Zakharov – Charles University in Prague and General University Hospital, Prague, Bohemia, Czech Republic
EDITORS IN CHIEF EMERITI
Steven Seifert - 2017–2022
E. Martin Caravati - 2012-2016
Nicholas Bateman - 2009–2011
Michael McGuigan - 2002–2009
Carol Angle - 1989–2002
Helmut Redetzki - 1981–1989
Richard Rappolt - 1968–1981
Abstracting and indexing
Clinical Toxicology is included in the following abstracting and indexing services:
Academic Search Complete; BIOBASE; Biological Abstracts; Biomedical Reference Collection: Comprehensive; BIOSIS Full Coverage Shared; BIOSIS Previews; Biotechnology Abstracts; Chemical Abstracts; Current Contents/Life Sciences; Derwent Drug File; Derwent Chimera; IDIS (Iowa Drug Information Service); EMBASE; EMBIOLOGY; Environment Complete; ETOH; Journal Citation Reports/Science Edition; Neuroscience Abstracts; PASCAL; PubMed/MedLine; PopLine; SciSearch; SCOPUS; Toxicology Abstracts; Zoological Record CABI Global Health; Agricultural Economics Database; Animal Production Database; Animal Science Database; Crop Science Database; Dairy Science Abstracts; Environmental Science Database; Leisure Tourism Database; Leisure; Recreation and Tourism Abstracts; Nutrition and Food Sciences Database; Rural Development Abstracts; and World Agricultural Economics; Rural Sociology Abstracts; Agricola; Index Veterinarius; Inpharma Weekly; Journal Watch Emergency Medicine; Pharmacoeconomics and Outcomes News; Reactions Weekly; Referativny Zhurnal; Tropical Diseases Bulletin.
Open access
Clinical Toxicology is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Use our APC finder to calculate your article publishing charge
12 issues per year
Currently known as:
- Clinical Toxicology (2005 - current)
Formerly known as
- Journal of Toxicology: Clinical Toxicology (1982 - 2004)
- Clinical Toxicology (1968 - 1981)
Advertising information
Would you like to advertise in Clinical Toxicology?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Clinical Toxicology.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors